CINECA IRIS Institutional Research Information System

GADDUCCI, ANGIOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 43.434
AS - Asia 30.966
EU - Europa 23.603
SA - Sud America 3.347
AF - Africa 540
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 17
Totale 101.942
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 41.632
CN - Cina 9.906
IT - Italia 9.551
SG - Singapore 9.101
HK - Hong Kong 4.576
SE - Svezia 2.872
BR - Brasile 2.801
KR - Corea 2.303
VN - Vietnam 2.014
UA - Ucraina 1.997
BG - Bulgaria 1.981
CA - Canada 1.517
DE - Germania 1.334
GB - Regno Unito 1.166
TR - Turchia 1.146
FR - Francia 1.144
FI - Finlandia 1.002
CH - Svizzera 903
RU - Federazione Russa 872
IN - India 433
JP - Giappone 375
BD - Bangladesh 209
AR - Argentina 195
NL - Olanda 149
IQ - Iraq 142
MX - Messico 111
ES - Italia 106
ZA - Sudafrica 100
PK - Pakistan 92
SA - Arabia Saudita 92
BE - Belgio 90
ID - Indonesia 90
VE - Venezuela 80
UZ - Uzbekistan 72
AT - Austria 71
CO - Colombia 66
EC - Ecuador 66
MA - Marocco 65
CI - Costa d'Avorio 61
PL - Polonia 58
SN - Senegal 47
PH - Filippine 45
IE - Irlanda 44
KE - Kenya 44
NG - Nigeria 43
CZ - Repubblica Ceca 40
JO - Giordania 39
EG - Egitto 38
BJ - Benin 35
PY - Paraguay 35
RO - Romania 35
CL - Cile 32
JM - Giamaica 32
AE - Emirati Arabi Uniti 30
MY - Malesia 30
PT - Portogallo 28
TT - Trinidad e Tobago 28
AU - Australia 27
IL - Israele 27
BO - Bolivia 25
NP - Nepal 25
TN - Tunisia 25
CR - Costa Rica 23
GR - Grecia 23
HU - Ungheria 22
OM - Oman 22
UY - Uruguay 21
AZ - Azerbaigian 20
LB - Libano 19
PE - Perù 19
TH - Thailandia 19
TW - Taiwan 18
DO - Repubblica Dominicana 16
DZ - Algeria 16
AL - Albania 15
EE - Estonia 15
ET - Etiopia 15
HN - Honduras 15
IR - Iran 15
KG - Kirghizistan 15
LT - Lituania 15
KZ - Kazakistan 14
RS - Serbia 13
GT - Guatemala 12
HR - Croazia 11
DK - Danimarca 10
EU - Europa 10
PA - Panama 9
KW - Kuwait 8
NI - Nicaragua 8
QA - Qatar 8
AO - Angola 7
PS - Palestinian Territory 7
BH - Bahrain 6
CY - Cipro 6
MN - Mongolia 6
NZ - Nuova Zelanda 6
AM - Armenia 5
BB - Barbados 5
BS - Bahamas 5
Totale 101.794
Salva come PNG Salva come JPEG
Città #
Singapore 5.233
Hong Kong 4.527
Ashburn 4.484
Milan 3.788
Chandler 3.225
Hefei 3.192
Jacksonville 2.702
Woodbridge 2.682
Ann Arbor 2.524
San Jose 2.477
Seoul 2.296
Fairfield 2.246
Dallas 2.166
Sofia 1.975
Houston 1.944
Shanghai 1.559
Ottawa 1.361
Beijing 1.314
New York 1.188
Santa Clara 1.058
Seattle 1.010
Wilmington 881
Boardman 867
Bern 845
Princeton 800
Lawrence 775
Nanjing 772
Cambridge 684
Lauterbourg 668
Izmir 632
Des Moines 620
Medford 596
Los Angeles 577
Dearborn 502
Jüchen 475
Ho Chi Minh City 464
Rome 391
Istanbul 378
Buffalo 367
Council Bluffs 360
Tokyo 341
Dong Ket 330
Hanoi 322
Nanchang 265
Helsinki 257
Redwood City 225
São Paulo 206
Kunming 200
San Diego 172
Boulder 154
Redondo Beach 152
Orem 134
Shenyang 134
Ogden 132
Frankfurt am Main 128
Changsha 114
Florence 114
Tianjin 113
Hebei 108
Munich 108
London 107
Chicago 94
Jiaxing 91
Brussels 85
Verona 84
Da Nang 83
Lancaster 82
Norwalk 78
Rio de Janeiro 76
Orange 75
Serra 72
Tashkent 68
Chennai 65
Düsseldorf 64
Guangzhou 64
Pune 63
Columbus 62
Hangzhou 62
The Dalles 62
Abidjan 60
Belo Horizonte 60
Baghdad 59
Brasília 58
Turin 58
Pisa 56
Dhaka 55
Vienna 52
Fuzhou 47
Curitiba 46
Dakar 46
Haiphong 44
Washington 44
Detroit 43
Porto Alegre 43
Changchun 42
Falls Church 42
Jinan 42
Manchester 42
Nuremberg 42
Atlanta 41
Totale 70.773
Salva come PNG Salva come JPEG
Nome #
Chemioterapia con CTX,DDP,ADM nel carcinoma ovarico in stadio avanzato 1.903
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 958
Isterectomia radicale secondo Wertheim-Meigs e radioterapia transcutanea postoperatoria con alte energie nel trattamento del carcinoma cervicale negli stadi Ib-II FIGO 418
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 331
Alfa2-macroglobulina e dismetabolismo glicidico in gravidanza 260
A comparison of several tumor markers in the diagnosis, monitoring and follow-up of patients with epithelial ovarian cancer 252
Chemioterapia neoadiuvante con schema PVB nel carcinoma cervicale avanzato. 251
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 233
Endometrial stromal sarco¬ma: Analysis of treatment failures and survival 223
D-dimer in gynecological cancer 221
Il recettore solubile dell' interleuchina-2(sIL-2r) nel carcinoma ovarico 220
Functional Interaction Between BRCA1 and DNA Repair in Yeast May Uncover a Role of RAD50, RAD51, MRE11A, and MSH6 Somatic Variants in Cancer Development. 219
Combined use of CA125 and CA15-3 in patients with endometrial carcinoma. 215
Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: Is local therapy with hyaluronic acid of clinical benefit? 213
Carboplatin, doxorubicin and cyclophosphamide versus cisplatin, doxorubicin and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma. 212
Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer 212
Prognostic value of lymph node status and number of removed nodes in patients with squamous cell carcinoma of the vulva treated with modified radical vulvectomy and inguinal-femoral lymphadenectomy. 209
Computerized tomography (CT) semeiotics in the presurgical evaluation of gynaecological neoplasias. 209
Computed tomography in the follow-up of gynaecological neoplasias 207
Porphyrin-sensitized phototreatment as a conservative therapy in gynaecological oncology 207
Il dosaggio sierico del recettore solubile della interleuchina-2 nelle neoplasie ginecologiche 205
La tomografia assiale computerizzata nel follow-up delle pazienti precedentemente trattate per neoplasie della cervice e del corpo uterino 203
Prospective multicenter study on CA 125 in postmenopausal pelvic masses. 201
Factors in malignant transformation of ovarian endometriosis: A narrative review 198
Wertheim's radical hysterectomy with pelvic lymphadenectomy in the treatment of cervical carcinoma at the Obstetric and Gynecological Clinic of the University of Pisa 198
Carcinoma developing in bladder exstrophy. Case report. 198
Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer 198
Valutazione del CA125, TPA, GICA, CEA nella diagnosi e nel monitoraggio del carcinoma ovarico. 197
Correlation of CA125 and CA19-9 serum levels with clinical course and second-look findings in patients with ovarian carcinoma 197
p53 nuclear accumulation in adenomatous hyperplasia and stage I endometrioid carcinoma. 197
Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: An Italian multicenter retrospective study (CTF study) 197
Micro-RNAs and ovarian cancer: The state of art and perspectives of clinical research 196
An analysis of approaches to the management of endome¬trial cancer in North America: A CTF study. 195
A comparison of the usefullness of serum measurements of CA125, CA50 and TATI in patients with malignant and benign gynecological pathology 193
Follow-up strategies in gynecological oncology: searching appropriateness 193
Prothrombin fragment F 1+ 2 and thrombin- antithrombin III complex (TAT) plasma levels in patients with gynecological cancer 192
Brenner's tumor 191
The role of the French-Italian glossary of complications in the outcome evaluation of cervical cancer treatment: an Italian multicentric study 190
Prognostic role of immunosuppres¬sive acidic protein in advanced ovarian cancer. 188
Novel targeted therapies in epithelial ovarian cancer: from basic research to the clinic 188
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest 187
The therapy of verrucous carcinoma of the vulva. Observations on three cases. 185
Evaluation of the central dopaminergic activity in gestational hyperprolactinaemia by means of the electroretinographic technique 184
Gynecological malignancies in elderly patients: is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study 184
Antiangiogenic agents in gynecological cancer: State of art and perspectives of clinical research 184
Discontinuation of modern hormonal contraceptives: an Italian survey 184
First-line chemothe¬rapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients 182
Metabolismo glicidico ed emoglobina glicosilata (HbA1) in gravidanza 181
The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis 181
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients. 181
Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study) 181
Management of peritoneal carcinomatosis with cytoreductive surgery combined with intraperitoneal chemohyperthermia at a novel italian center 181
Adjuvant treatment of stage I-II malignant mixed mesodermal tumors (MMMT) of the uterus: a multicenter CTF study 180
Current management of fallopian tube carcinoma 179
Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature 179
Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: A debated clinical issue 179
Aspetti colposcopici, citologici, e istologici dell'endometriosi cervicale. 178
Serum solule interleukin-receptor (sIL-2R) assay in cervical an endometrial cancer. Preliminary data. 178
Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature 178
Adjuvant treatment of early stage ovarian carcinoma. 177
Fattori prognostici nei tumori misti mulleriani maligni (MMMT) dell' utero al I-II stadio: uno studio CTF 177
The role of computerized tomography of the pelvis in the presurgical staging of carcinoma of the cervix and of the ovary Eur.J. Gynaec. 176
Iperprolattinemia e stati depressivi 176
Factor VIIIR: Ag plasma levels in patients with cervical and ovarian carcinoma 176
Assenza di alterazioni dell'oncogene MDM-2 nel carcinoma ovarico 176
Struma ovarii 175
A comparative evaluation of the ability of serum CA125, CA19-9, CA15-3, CA50, CA72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma 175
Preoperative evaluation of D-Dimer and CA 125 levels in differentiating benign from malignant ovarian masses. 175
Uterine leiomyosarcoma: Analysis of treatment failures and survival 175
Weekly epirubicin in the treatment of gestational breast cancer (GBC) 175
Pharmacological treatment for uterine leiomyosarcomas 175
Epidoxorubicin (EPI-DX) and lonidamine (LND) in refractory or recurrent epithelial ovarian cancer (EOC) 174
Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. 174
Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer. 174
Clinical Outcomes of Stereotactic Body Radiotherapy in Oligometastatic Gynecological Cancer 174
Le complicanze postoperatorie dell'intervento di laparoisterectomia radicale con linfadenectomia pelvica 173
Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study 173
Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer 173
Hemorrhagic uterine necrosis after surgical vessel ligation and B-Lynch suture in persistent post-cesarean uterine atony: case report and review of literature 173
Sistema immunitario e carcinoma ovarico 172
Porfirine e luce visibile nella diagnosi e nella terapia delle neoplasie. Prime esperienze cliniche in oncologia ginecologica. 172
A combination of CA125, CA19-9, CA15-3, CA50, CA72-4 and TATI in the monitoring of ovarian carcinoma 172
Surgery and radiotherapy in the treatment of early stage uterine sarcomas. 172
Minimization of cisplatin nephrotoxicity in high-risk patients 171
Presidi farmacologici nel controllo dell'emesi indotta dalla chemioterapia per neoplasie maligne ginecologiche 170
The topical administration of steroids in the treatment of typical vulvar dystrophy. 170
The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patients 170
Management of borderline ovarian tumors: Results of an Italian multicenter study 170
Squamous cell carcinoma of the vagina: Natural history, treatment modalities and prognostic factors 170
A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma. 169
Verrucous carcinoma of the cervix 169
Iperespressione della proteina p53 nella iperplasia endometriale e nel carcinoma endonmetriale in I stadio 169
Carcinosarcoma of the uterus : a clinicopathological multicenter CTF study 169
Analysis of failures in patients with stage I ovarian cancer: an Italian multicenter study 168
Prognostic factors in uterine sarcoma 168
P53 overexpression in ovarian cancer: correlation with clinicopathological parameters and chemosensitivity 167
Fertility drug use and risk of ovarian tumors: a debated clinical challenge 167
Evaluation of FHIT gene alterations in ovarian cancer 167
Pregnancy-associated cancers: Frequency and temporal trends in Italy 167
Importanza delle prove da carico per la valutazione della tolleranza glucidica in gravidanza. 166
Totale 21.585
Salva come PNG Salva come JPEG
Categoria #
all - tutte 282.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 282.832
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.668 194 545 307 678 1.516 1.000 189 360 281 148 344 2.106
2022/20238.048 1.124 683 424 699 1.172 1.282 115 727 1.124 58 531 109
2023/202410.127 1.958 1.282 1.654 828 1.404 1.301 266 302 169 121 135 707
2024/202521.707 149 1.021 226 1.116 958 1.255 1.727 1.287 2.161 2.959 3.334 5.514
2025/202623.762 1.864 4.439 3.375 1.856 1.681 2.376 3.419 992 942 1.897 628 293
2026/2027107 107 0 0 0 0 0 0 0 0 0 0 0
Totale 102.508